Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (2) , 174-178
- https://doi.org/10.1016/0277-5379(91)90481-r
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Ofloxacin versus Vancomycin/Polymyxin for prevention of infections in granulocytopenic patientsThe American Journal of Medicine, 1990
- Impact of Fluoroquinolones on the Gastrointestinal FloraClinical Infectious Diseases, 1989
- Long-Term Use of Quinolones and Their SafetyClinical Infectious Diseases, 1989
- Pharmacokinetics and Clinical Results of Parenterally Administered New Quinolones in HumansClinical Infectious Diseases, 1989
- Ofloxacin for prevention of bacterial infections in granulocytopenic patientsInfection, 1987
- Norfloxacin for prevention of bacterial infections in granulocytopenic patientsThe American Journal of Medicine, 1987
- The comparative pharmacokinetics of five quinolonesJournal of Antimicrobial Chemotherapy, 1986
- Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patientsThe American Journal of Medicine, 1986
- Approaching the controversies in antibacterial management of cancer patientsThe American Journal of Medicine, 1984
- Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols.A clinical-pathologic study of 33 patientsCancer, 1978